Abstract

Translational research has been transformed by organoid biotechnology, which offers physiologically realistic in vitro systems for regenerative medicine, tailored therapies, and disease modeling. The biochemical microenvironments that direct the creation of organoids are examined in this study, with a focus on the dynamics of the extracellular matrix and important signaling pathways like Wnt, Notch, BMP, and Hedgehog. As shown from previous research, one of the factors driving precision biomedicine is the combination of organoid systems and CRISPR-based gene editing. In addition to the review on advances made on vascularization, repeatability, and scale-up for clinical translation, we examine recent developments in organoid engineering, biobanking, and drug screening. The review finally highlights organoids as a crucial nexus between biochemistry and biotechnology, with growing uses in innovative healthcare.